SELECT MEDICAL HOLDINGS CORP (SEM) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:SEM • US81619Q1058

15.035 USD
-0.04 (-0.3%)
Last: Feb 3, 2026, 11:40 AM
Fundamental Rating

4

Taking everything into account, SEM scores 4 out of 10 in our fundamental rating. SEM was compared to 102 industry peers in the Health Care Providers & Services industry. SEM has a medium profitability rating, but doesn't score so well on its financial health evaluation. SEM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SEM had positive earnings in the past year.
  • In the past year SEM had a positive cash flow from operations.
  • Each year in the past 5 years SEM has been profitable.
  • SEM had a positive operating cash flow in each of the past 5 years.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • With a decent Return On Assets value of 3.72%, SEM is doing good in the industry, outperforming 67.65% of the companies in the same industry.
  • SEM's Return On Equity of 12.53% is fine compared to the rest of the industry. SEM outperforms 77.45% of its industry peers.
  • With a Return On Invested Capital value of 4.34%, SEM perfoms like the industry average, outperforming 50.98% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SEM is significantly below the industry average of 9.16%.
  • The last Return On Invested Capital (4.34%) for SEM is above the 3 year average (3.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROIC 4.34%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • SEM's Profit Margin of 4.08% is fine compared to the rest of the industry. SEM outperforms 75.49% of its industry peers.
  • SEM's Profit Margin has improved in the last couple of years.
  • SEM has a Operating Margin of 5.17%. This is in the better half of the industry: SEM outperforms 64.71% of its industry peers.
  • In the last couple of years the Operating Margin of SEM has declined.
  • SEM has a Gross Margin of 12.22%. This is in the lower half of the industry: SEM underperforms 70.59% of its industry peers.
  • SEM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SEM is destroying value.
  • The number of shares outstanding for SEM has been increased compared to 1 year ago.
  • Compared to 5 years ago, SEM has less shares outstanding
  • Compared to 1 year ago, SEM has an improved debt to assets ratio.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • SEM has an Altman-Z score of 1.57. This is a bad value and indicates that SEM is not financially healthy and even has some risk of bankruptcy.
  • SEM has a Altman-Z score of 1.57. This is comparable to the rest of the industry: SEM outperforms 41.18% of its industry peers.
  • SEM has a debt to FCF ratio of 10.18. This is a negative value and a sign of low solvency as SEM would need 10.18 years to pay back of all of its debts.
  • SEM has a Debt to FCF ratio (10.18) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that SEM has dependencies on debt financing.
  • SEM has a Debt to Equity ratio of 1.03. This is in the lower half of the industry: SEM underperforms 62.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Altman-Z 1.57
ROIC/WACC0.43
WACC10.04%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • SEM has a Current Ratio of 1.09. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SEM (1.09) is worse than 63.73% of its industry peers.
  • A Quick Ratio of 1.09 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM has a Quick ratio (1.09) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1

3. Growth

3.1 Past

  • SEM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.81%.
  • SEM shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.88% yearly.
  • The Revenue has been growing slightly by 7.48% in the past year.
  • Measured over the past years, SEM shows a decrease in Revenue. The Revenue has been decreasing by -1.00% on average per year.
EPS 1Y (TTM)-59.81%
EPS 3Y-17.89%
EPS 5Y5.88%
EPS Q2Q%-46.51%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y-5.8%
Revenue growth 5Y-1%
Sales Q2Q%-22.59%

3.2 Future

  • Based on estimates for the next years, SEM will show a small growth in Earnings Per Share. The EPS will grow by 5.83% on average per year.
  • The Revenue is expected to decrease by -2.85% on average over the next years.
EPS Next Y-24.52%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
EPS Next 5Y5.83%
Revenue Next Year-16.41%
Revenue Next 2Y-6.62%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.48 indicates a rather expensive valuation of SEM.
  • Compared to the rest of the industry, the Price/Earnings ratio of SEM indicates a somewhat cheap valuation: SEM is cheaper than 77.45% of the companies listed in the same industry.
  • SEM is valuated rather cheaply when we compare the Price/Earnings ratio to 28.41, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 11.36, which indicates a very decent valuation of SEM.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SEM indicates a rather cheap valuation: SEM is cheaper than 85.29% of the companies listed in the same industry.
  • SEM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.64.
Industry RankSector Rank
PE 17.48
Fwd PE 11.36
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SEM indicates a somewhat cheap valuation: SEM is cheaper than 76.47% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, SEM is valued cheaply inside the industry as 84.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.7
EV/EBITDA 8.56
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The decent profitability rating of SEM may justify a higher PE ratio.
  • SEM's earnings are expected to decrease with -2.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.97
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%

5

5. Dividend

5.1 Amount

  • SEM has a Yearly Dividend Yield of 1.67%. Purely for dividend investing, there may be better candidates out there.
  • SEM's Dividend Yield is rather good when compared to the industry average which is at 0.47. SEM pays more dividend than 88.24% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, SEM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • SEM has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • SEM pays out 18.80% of its income as dividend. This is a sustainable payout ratio.
DP18.8%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (2/3/2026, 11:40:26 AM)

15.035

-0.04 (-0.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-19
Inst Owners82.91%
Inst Owner Change-2.29%
Ins Owners11.06%
Ins Owner Change0.26%
Market Cap1.86B
Revenue(TTM)5.19B
Net Income(TTM)211.72M
Analysts77.78
Price Target18.53 (23.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP18.8%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.01%
Min EPS beat(2)30.21%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)-20.63%
Min EPS beat(4)-158.51%
Max EPS beat(4)49.82%
EPS beat(8)4
Avg EPS beat(8)-7.1%
EPS beat(12)7
Avg EPS beat(12)-2.62%
EPS beat(16)9
Avg EPS beat(16)-3.49%
Revenue beat(2)1
Avg Revenue beat(2)0.08%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-3.63%
Min Revenue beat(4)-11.07%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.53%
Revenue beat(12)7
Avg Revenue beat(12)-0.91%
Revenue beat(16)10
Avg Revenue beat(16)5.68%
PT rev (1m)0%
PT rev (3m)0.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.03%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)6.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE 17.48
Fwd PE 11.36
P/S 0.36
P/FCF 10.7
P/OCF 4.57
P/B 1.1
P/tB N/A
EV/EBITDA 8.56
EPS(TTM)0.86
EY5.72%
EPS(NY)1.32
Fwd EY8.81%
FCF(TTM)1.41
FCFY9.35%
OCF(TTM)3.29
OCFY21.89%
SpS41.89
BVpS13.64
TBVpS-6.02
PEG (NY)N/A
PEG (5Y)2.97
Graham Number16.25
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROCE 5.65%
ROIC 4.34%
ROICexc 4.39%
ROICexgc 9.14%
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
FCFM 3.35%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
ROICexc(3y)3.14%
ROICexc(5y)4.99%
ROICexgc(3y)6.3%
ROICexgc(5y)12.6%
ROCE(3y)4.06%
ROCE(5y)6.32%
ROICexgc growth 3Y-27.06%
ROICexgc growth 5Y-9.65%
ROICexc growth 3Y-20.88%
ROICexc growth 5Y-5.51%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
F-Score5
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Debt/EBITDA 4.17
Cap/Depr 155.87%
Cap/Sales 4.5%
Interest Coverage 2.17
Cash Conversion 97.47%
Profit Quality 82.19%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 1.57
F-Score5
WACC10.04%
ROIC/WACC0.43
Cap/Depr(3y)103.75%
Cap/Depr(5y)94.3%
Cap/Sales(3y)4.39%
Cap/Sales(5y)3.74%
Profit Quality(3y)115.02%
Profit Quality(5y)150.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-59.81%
EPS 3Y-17.89%
EPS 5Y5.88%
EPS Q2Q%-46.51%
EPS Next Y-24.52%
EPS Next 2Y-10.42%
EPS Next 3Y-2.53%
EPS Next 5Y5.83%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y-5.8%
Revenue growth 5Y-1%
Sales Q2Q%-22.59%
Revenue Next Year-16.41%
Revenue Next 2Y-6.62%
Revenue Next 3Y-2.85%
Revenue Next 5YN/A
EBIT growth 1Y0.4%
EBIT growth 3Y-27.83%
EBIT growth 5Y-10.68%
EBIT Next Year-15.98%
EBIT Next 3Y-1.14%
EBIT Next 5YN/A
FCF growth 1Y-9.04%
FCF growth 3Y10.24%
FCF growth 5Y0.52%
OCF growth 1Y-1.83%
OCF growth 3Y8.88%
OCF growth 5Y3.07%

SELECT MEDICAL HOLDINGS CORP / SEM FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 6 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 17.48 and the Price/Book (PB) ratio is 1.1.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 3 / 10.